Updated:
DeepCardio
DeepCardio backs AI startups in cardiac diagnostics from Incheon, South Korea, focusing on digital health and machine learning for cardiovascular care.
Overview
Deepcardio, a Seoul, South Korea-based company, was founded in 2020. The company has secured $3,076,923 in total funding.
General information
Firm type
Asset Manager
Location
Region
Asia
Country
South Korea
City
Incheon
Corporate office
Incheon, South Korea
Sector focus
Frequently asked questions
What does DeepCardio invest in?
DeepCardio invests in startups applying AI and machine learning to cardiac diagnostics. Focus areas include ECG analysis, medical imaging for the heart, and remote monitoring technologies. The firm targets early-stage companies in Asia.
Where is DeepCardio based?
DeepCardio is headquartered in Incheon, South Korea. Its operations are focused on Asian markets.
How does DeepCardio deploy capital?
DeepCardio deploys capital through direct investments in startups. It does not appear to operate fund-of-funds or major secondary structures based on available information.
Who runs DeepCardio?
Named principals are not publicly disclosed for DeepCardio. The firm's leadership is not identifiable from public records.
What is the investment stage for DeepCardio?
DeepCardio targets startups, implying early-stage investments. No specific stage band—seed, Series A, etc.—is confirmed.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: